MKI The Medipattern Corp.

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES

Attention: Business/Financial Editors 

The Medipattern Corporation ("Medipattern" or the "Company") (TSX VENTURE:MKI),
a healthcare leader in the development and commercialization of prevention and
analysis solutions that positively impact people's lives, announced that it has
arranged a term debt facility (the "Facility") to provide up to $1,000,000 of
working capital. The Facility calls for advances to be made monthly to the
Company, initially for $100,000, in exchange for secured notes to be issued by
the Company under the Facility (the "Notes"). The Notes will mature on June 30,
2013, and will bear interest at the rate of 6% per annum, calculated monthly and
payable at maturity. The Notes will be secured by a general security agreement
over all the assets of the Company, in priority to all existing security
interests granted by the Company. The closing of the Facility and the initial
$100,000 monthly advance for Notes is subject to completion of definitive
documents, and TSX Venture Exchange approval. The Notes are subject to certain
redemption and repayment rights. Medipattern and its Board have agreed the
holders of the Notes have the right to appoint up to two (2) representatives as
directors to the Company's Board. 


The proceeds from the Notes will be used by Medipattern to provide working
capital in further support of its Visualize:Vascular(TM) sales efforts. The
Company has determined that the initial results from its Visualize:Vascular
trials merit a reallocation of resources towards the expansion of the program.
In light of this development, the Company has recently implemented a
comprehensive restructuring plan that reduces certain operating costs while
increasing emphasis on Visualize:Vascular sales. Specifically, the US sales
force and customer support for Visualize:Vascular have been increased. Sales of
Visualize:Vascular are now targeted at the US medical market where the product
is currently installed and being used in eight (8) states: New York, New Jersey,
California, Pennsylvania, Connecticut, Massachusetts, North Carolina, and New
Hampshire. Customers submitting medical claims for using Visualize:Vascular have
been reimbursed by all of the major payers and in a recently reviewed paper, it
was shown to be highly effective in determining luminal reduction correlating
well with Magnetic Resonance Angiography (MRA). The Company will continue to
pursue leads for its mHealth business unit in conjunction with its
Visualize:Vascular efforts as it develops its physician prescribed model for its
SmartCoach product.


All Notes issued under the Facility are subject to a four month and one day
resale restriction and are subject to TSX Venture Exchange acceptance of
requisite regulatory filings. 


The securities offered in the placement have not been and will not be registered
under the United States Securities Act of 1933, as amended, (the "U.S.
Securities Act"), and may not be offered or sold within the United States or to,
or for the account or benefit of U.S. persons except in certain transactions
exempt from the registration requirements of the U.S. Securities Act.


About the Medipattern Corporation:

Medipattern(R) is an award-winning leader in the development and
commercialization of healthcare solutions that positively impact people's lives
through the prevention of disease and analysis of medical images and data.
Medipattern's Knowledge-based Informatics (MKI) platform enables delivery of
these streamlined solutions. Medipattern mHealth uses patented prevention
technologies to engage, coach and monitor people in achieving their personalized
goals. Medipattern iaHealth uses patented pattern recognition technology to
analyze medical data to aid medical practitioners in the assessment of disease
and critical anatomy. For more information, please visit the Company's website:
www.medipattern.com.


Medipattern(R) is registered trademarks of The Medipattern Corporation.
Visualize:Vascular(TM) is a registered trademark of Medipattern.


Forward-looking statements

This document contains forward-looking statements relating to Medipattern's
performance, operations, or business environment. These statements are based on
what we believe are reasonable assumptions given currently available information
and our understanding of Medipattern's current activities. We have tried,
whenever possible, to identify these forward-looking statements using words such
as "anticipates," "believes," "estimates," "expects," "plans," "intends,"
"potential", and similar expressions. Forward-looking statements are not
guarantees of future performance and involve risks and uncertainties that are
difficult to predict or control. A number of factors could cause actual outcomes
and results to differ materially from those expressed in forward-looking
statements. These factors include but are not limited to those set forth in the
Company's corporate filings, (posted at www.sedar.com). These factors should be
considered carefully, and readers should not place undue reliance on
Medipattern's forward-looking statements. In addition, these forward-looking
statements relate to the date on which they are made. The Company disclaims any
intention or obligation to update or revise any forward-looking statements for
any reason. Readers should not rely on forward-looking statements.


FOR FURTHER INFORMATION PLEASE CONTACT: 
The Medipattern Corporation
Jeff Collins
CEO
(416) 744-0009 ext. 224
jcollins@medipattern.com
www.medipattern.com


Spinnaker Capital Markets Inc.
Kevin O'Connor
(416) 962-3300 ext. 226
ko@spinnakercmi.com

The Medipattern Corp. (TSXV:MKI)
Historical Stock Chart
From May 2024 to Jun 2024

The Medipattern Corp. (TSXV:MKI)
Historical Stock Chart
From Jun 2023 to Jun 2024